BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1209540)

  • 1. Formation and detection of fibrinogen derived complexes.
    Latallo ZS
    Thromb Diath Haemorrh; 1975 Dec; 34(3):677-85. PubMed ID: 1209540
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.
    Konttinen YP; Kemppainen L; Turunen O
    Thromb Diath Haemorrh; 1972 Dec; 28(3):342-50. PubMed ID: 4675265
    [No Abstract]   [Full Text] [Related]  

  • 3. [Detection of factor XIII deficiency in acute leukemia with resonance thrombography].
    Anders O; Görss EW; Ernst B; Konrad H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(5):670-9. PubMed ID: 2448208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detection of fibrinogen and fibrin degradation products (FDP) and its clinical significance].
    Fujimaki M; Ikematsu S; Takeuchi I
    Nihon Rinsho; 1973 Apr; 31(4):798-804. PubMed ID: 4580396
    [No Abstract]   [Full Text] [Related]  

  • 5. [Content of soluble fibrin monomeric complexes, factor XIII and fibrin(ogen) degradation products in neonatal asphyxia].
    Suzuki S; Graeff H; Hafter R
    Arch Gynecol; 1979 Jul; 228(1-4):626-7. PubMed ID: 485520
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrin-fibrinogen degradation products in allergic disorders.
    Palma-Carlos AG; de Sá A; Joana-Geraldes M; Ducla-Soares J; Migueis-Clode MH
    Allergol Immunopathol (Madr); 1974; 2(6):419-22. PubMed ID: 4282697
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fibrinogen B (soluble fibrinogen), its nature and methods of determination].
    Belitser VA
    Lab Delo; 1980; (9):529-32. PubMed ID: 6157920
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 9. Soluble crosslinked fibrin(ogen) polymers.
    Selmayr E; Müller-Berghaus G
    Thromb Haemost; 1985 Dec; 54(4):804-7. PubMed ID: 4089815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of soluble fibrin monomer complexes. Comparison of a haemagglutination assay with the ethanol gelation test.
    Oehler G; Klaus H; Stötzer KE; Spanuth E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):278-83. PubMed ID: 2465216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinogen and fibrin degradation products].
    Fujimaki M; Ikematsu S; Kato M
    Rinsho Byori; 1973 Jan; 21(1):31-6. PubMed ID: 4267650
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of soluble fibrin monomer complexes (SFMC) and plasma fibrinogen in acute myocardial infarction.
    Jain SM; Trivedi S
    Indian J Chest Dis Allied Sci; 1984; 26(2):98-103. PubMed ID: 6530267
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Soluble fibrin monomer complexes in thromboembolism].
    Gryglik J
    Przegl Lek; 1982 Sep; 39(8):551-3. PubMed ID: 6753042
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of sodium and calcium on the conversion of fibrinogen to fibrin].
    Marguerie G; Hudry G; Hollard D
    Thromb Diath Haemorrh; 1970 Dec; 24(3):373-84. PubMed ID: 5503938
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of anesthesia on blood coagulation factor XIII].
    Homann B; Blumenberg D; Lerner H
    Anaesthesist; 1984 Mar; 33(3):145-8. PubMed ID: 6721127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deposition of fibrin-stabilizing factor (F XIIIA and S), fibrinogen-related antigens, fibrinogen degradation products (FDPd and FDPe) and antihemolytic factor (F VIII) in renal disease: analysis of 161 cases by immunofluorescence microscopy.
    Colasanti G; Morel Maroger L; D'Amico G
    Clin Nephrol; 1987 Jul; 28(1):28-34. PubMed ID: 3113791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Interaction of fibrinogen with two forms of fibrin differing in the degree of activation by thrombin].
    Belitser VA; Lugovskoĭ EV; Ugarova TP; Derzskaia SG
    Biokhimiia; 1985 Aug; 50(8):1336-41. PubMed ID: 4074798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinogen-fibrin degradation products and factor XIII.
    Miloszewski K; Sheltawy MJ; Losowsky MS
    Acta Haematol; 1974; 51(6):321-30. PubMed ID: 4212013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.